Extrastriatal and striatal D2 dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia

British Journal of Psychiatry

Volumn 179, Issue DEC., 2001, Pages 503-508

  Xiberas, X ^a   Martinot, J L ^a   Mallet, L ^a   Artiges, E ^a   Loc'h, C ^a   Maziere B ^a   Paillere Martinot M L ^a  

^a DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; CLOZAPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; ISOREMOXIPRIDE BR 76; NEUROLEPTIC AGENT; OLANZAPINE; RADIOPHARMACEUTICAL AGENT; RISPERIDONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RECEPTOR BLOCKING; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; TEMPORAL CORTEX; THALAMUS;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; FEMALE; HALOPERIDOL; HUMANS; MALE; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; TEMPORAL LOBE; THALAMUS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035675612     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.179.6.503     Document Type: Article

References (30)

1. Brain dopamine and serotonin receptor sites revealed by digital subtraction autoradiography
2. 123I]-epidepride single photon emission tomography (SPET) study
3. 123I]epidepride single photon emission tomography (SPET) study
4. 2 dopamine and muscarinic cholinergic receptors in rat striatum
5. Binding interaction of lysergic acid diethylamide and related agents with dopamine receptors in the brain
6. Comparison of the in vitro receptor selectivity of substituted benzamine drugs for the brain neurotransmitter receptors
7. Amisulpride. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of schizophrenia
8. 2 receptors using a very high affinity ligand (FLB 457) and the multi-injection approach
9. Substituted benzamides as ligand for visualization of dopamine receptor binding in the human brain by positron emission tomography
10. 2 dopamine receptor occupancy in patients treated with classical antipsychotics and clozapine. Relation to extrapyramidal side effects
11. Effects of typical and atypical antipsychotics on Fos protein expression in the rat forebrain
12. Clozapine. A review of its pharmacological properties and therapeutic use in schizophrenia
13. Risperidone and olanzapine: Optimal dosing for efficacy and tolerability in patients with schizophrenia
14. 123I-epidepride
15. 2-dopaminergic receptors in the primate cerebral cortex
16. 2 receptors with PET
17. Fast nonsupervised 3D registration of PET and MRI images of the brain
18. 2 receptor blockade and antipsychotic effects of neuroleptics. Preliminary study with PET
19. State of the art of drug treatment of schizophrenia and the future position of novel/atypical antipsychotics
20. The regulation of forebrain dopamine transmission: Relevance to the pathophysiology and psychopathology of schizophrenia
21. 2 dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients
22. 2A receptor occupancy in schizophrenic patients
23. Limbic selectivity of clozapine
24. 3 receptor antagonist with both presynaptic and limbic selectivity
25. 123I]-epidepride single photon emission tomography (SPET) study
26. On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs
27. 2 dopamine receptor blockade by amisulpride in schizophrenia
28. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group